Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007/12/28 by Reva C. Lawrence, David T. Felson, Charles G. Helmick +14 · 5,538 citations
Medicine · #Alternative medicine #Carpal tunnel syndrome #Demography #Environmental health #Fibromyalgia #Fibromyalgia and Chronic Fatigue Syndrome Research #Giant cell arteritis #Gout #Internal medicine #Medicine #National Health and Nutrition Examination Survey #Neck pain #Osteoarthritis Treatment and Mechanisms #Pathology #Physical therapy #Polymyalgia rheumatica #Population #Surgery #Vasculitis #Vasculitis and related conditions
paper · doi:10.1002/art.23176
published in Arthritis & Rheumatism 58(1), 26-35 (Wiley)
openalex publication_date 2007/12/28 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Abstract
OBJECTIVE: To provide a single source for the best available estimates of the US prevalence of and number of individuals affected by osteoarthritis, polymyalgia rheumatica and giant cell arteritis, gout, fibromyalgia, and carpal tunnel syndrome, as well as the symptoms of neck and back pain. A companion article (part I) addresses additional conditions. METHODS: The National Arthritis Data Workgroup reviewed published analyses from available national surveys, such as the National Health and Nutrition Examination Survey and the National Health Interview Survey. Because data based on national population samples are unavailable for most specific rheumatic conditions, we derived estimates from published studies of smaller, defined populations. For specific conditions, the best available prevalence estimates were applied to the corresponding 2005 US population estimates from the Census Bureau, to estimate the number affected with each condition. RESULTS: We estimated that among US adults, nearly 27 million have clinical osteoarthritis (up from the estimate of 21 million for 1995), 711,000 have polymyalgia rheumatica, 228,000 have giant cell arteritis, up to 3.0 million have had self-reported gout in the past year (up from the estimate of 2.1 million for 1995), 5.0 million have fibromyalgia, 4-10 million have carpal tunnel syndrome, 59 million have had low back pain in the past 3 months, and 30.1 million have had neck pain in the past 3 months. CONCLUSION: Estimates for many specific rheumatic conditions rely on a few, small studies of uncertain generalizability to the US population. This report provides the best available prevalence estimates for the US, but for most specific conditions more studies generalizable to the US or addressing understudied populations are needed.
Citations
Cited by
- Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007
- Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases
- Systematic Review of the Prevalence of Radiographic Primary Hip Osteoarthritis
- Intra-articular Knee Injections and Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- Mini review: Biomaterials in repair and regeneration of nerve in a volumetric muscle loss
- Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans
- Fibromyalgia severity and symptoms are associated with the disorders of gut–brain interaction
- Running and Knee Osteoarthritis: A Systematic Review and Meta-analysis
- Six‐week gait retraining program reduces knee adduction moment, reduces pain, and improves function for individuals with medial compartment knee osteoarthritis
- Reliability and Sensitivity of the Self-report of Physician-diagnosed Gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community Cohorts
- A proposed model of naturally occurring osteoarthritis in the domestic rabbit
- The impact of social determinants of health on the presentation, management and outcomes of systemic lupus erythematosus
- The effects of a sleeve knee brace during stair negotiation in patients with symptomatic patellofemoral osteoarthritis
- Epidemiology of Osteoarthritis
- Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment
- The role of macrophages in osteoarthritis and cartilage repair
- A comprehensive review of nanotechnology based drug delivery systems for osteoarthritis treatment
- Intra‐articular Pure Platelet‐Rich Plasma Combined With Open‐Wedge High Tibial Osteotomy Improves Clinical Outcomes and Minimal Joint Space Width Compared With High Tibial Osteotomy Alone in Knee Osteoarthritis: A Prospective Study
- Rheumatoid arthritis and risk of acute myocardial infarction—A nationwide retrospective cohort study
- Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- Economic Potential for Distributed Manufacturing of Adaptive Aids for Arthritis Patients in the U.S.
- The Role of Antidepressants in the Management of Fibromyalgia Syndrome
- Abatacept for rheumatoid arthritis
- Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- The epidemiology and impact of pain in osteoarthritis
- Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial
- Incidental meniscal findings on knee MRI in middle-aged and elderly persons. [europepmc]
- Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. [europepmc]
- The rising prevalence of chronic low back pain. [europepmc]
- Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. [europepmc]
- MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. [europepmc]
- Why is osteoarthritis an age-related disease? [europepmc]
- The role of tissue engineering in articular cartilage repair and regeneration. [europepmc]
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. [europepmc]
- Epidemiology of osteoarthritis. [europepmc]
- The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. [europepmc]
- The role of synovitis in osteoarthritis pathogenesis. [europepmc]
- Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. [europepmc]
- Epidemiology of osteoarthritis. [europepmc]
- Epidemiology and burden of osteoarthritis. [europepmc]
- Surgery versus physical therapy for a meniscal tear and osteoarthritis. [europepmc]
- The epidemiology and impact of pain in osteoarthritis. [europepmc]
- Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. [europepmc]
- Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. [europepmc]
- Opioids for low back pain. [europepmc]
- Animal models of osteoarthritis: classification, update, and measurement of outcomes. [europepmc]
- Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. [europepmc]
- Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. [europepmc]
- Senescent cells: an emerging target for diseases of ageing. [europepmc]
- Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. [europepmc]
- Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF- κ B/MAPK signaling and protecting chondrocytes. [europepmc]
Related